NSE: NIFTYPHARMA

21275.15 -85.45 (-0.40%)

NSE 27 Mar, 2025 3:31 PM (IST)

Nifty Pharma PB	5.2
Nifty Pharma PE	32.2
Nifty Pharma DIV	0.7
Nifty Pharma EPS	661.8

Nifty Pharma News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Sun Pharmaceutical Industries Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Sun Pharmaceutical Industries Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news and updates on Nifty Pharma from all sources in a single place.

Load latest

Is Nifty Pharma worth buying?

303 Votes:

Buy 79.21%

Sell 11.55%

Hold 9.24%